- decreased circulating HDL cholesterol level / IMPC
- increased circulating calcium level / IMPC
- increased heart weight / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating creatinine level / IMPC
- increased circulating amylase level / IMPC
- decreased circulating fructosamine level / IMPC
- increased circulating magnesium level / IMPC
- hyperplasia / IMPC
- extramedullary hemopoiesis / IMPC
B6Brd;B6N-Tyrc-Brd Slc16a2tm1a(KOMP)Wtsi/WtsiCnrm
Status | Available to order |
EMMA ID | EM:15234 |
International strain name | B6Brd;B6N-Tyrc-Brd Slc16a2tm1a(KOMP)Wtsi/WtsiCnrm |
Alternative name | EPD0109_3_E07 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc16a2tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Slc16a2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0109_3_E07. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References |
|
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Allan-Herndon-Dudley syndrome / Orphanet_59
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- decreased circulating fructosamine level / IMPC
- hyperplasia / IMPC
- increased heart weight / IMPC
- extramedullary hemopoiesis / IMPC
- increased circulating magnesium level / IMPC
- decreased circulating HDL cholesterol level / IMPC
- decreased circulating cholesterol level / IMPC
- increased circulating calcium level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased circulating creatinine level / IMPC
- increased circulating amylase level / IMPC
MGI phenotypes (allele matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- increased circulating alkaline phosphatase level / MGI
- decreased circulating cholesterol level / MGI
- decreased circulating creatinine level / MGI
- increased circulating amylase level / MGI
- decreased circulating fructosamine level / MGI
MGI phenotypes (gene matching)
- decreased circulating LDL cholesterol level / MGI
- decreased circulating HDL cholesterol level / MGI
- increased circulating alkaline phosphatase level / MGI
- nervous system phenotype / MGI
- decreased circulating cholesterol level / MGI
- abnormal circulating hormone level / MGI
- abnormal thyroxine level / MGI
- abnormal triiodothyronine level / MGI
- increased triiodothyronine level / MGI
- decreased circulating thyroxine level / MGI
- increased circulating triiodothyronine level / MGI
- decreased circulating creatinine level / MGI
- increased circulating amylase level / MGI
- decreased circulating fructosamine level / MGI
Literature references
- Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes.;White Jacqueline K, Gerdin Anna-Karin, Karp Natasha A, Ryder Ed, Buljan Marija, Bussell James N, Salisbury Jennifer, Clare Simon, Ingham Neil J, Podrini Christine, Houghton Richard, Estabel Jeanne, Bottomley Joanna R, Melvin David G, Sunter David, Adams Niels C, null null, Tannahill David, Logan Darren W, Macarthur Daniel G, Flint Jonathan, Mahajan Vinit B, Tsang Stephen H, Smyth Ian, Watt Fiona M, Skarnes William C, Dougan Gordon, Adams David J, Ramirez-Solis Ramiro, Bradley Allan, Steel Karen P, ;2013;Cell;154;452-64; 23870131
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).